A novel amino acid substitution in the reactive site of a congenital variant antithrombin
Open Access
- 1 June 1989
- journal article
- Published by Elsevier
- Vol. 264 (17) , 10200-10204
- https://doi.org/10.1016/s0021-9258(18)81785-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosisBritish Journal of Haematology, 1989
- Antithrombin III Utah: proline-407 to leucine mutation in a highly conserved region near the inhibitor reactive siteBiochemistry, 1988
- Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.Journal of Clinical Investigation, 1988
- On the domain structure of antithrombin III. Tentative localization of the heparin binding region using proton NMR spectroscopyBiochemistry, 1987
- Antithrombin III alger: A new case of Arg 47 ← cys mutationAmerican Journal of Hematology, 1987
- Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing patternBritish Journal of Haematology, 1987
- Restriction sites containing CpG show a higher frequency of polymorphism in human DNACell, 1984
- Molecular Heterogeneity of Inherited Antithrombin III DeficiencyNew England Journal of Medicine, 1983
- Fast atom bombardment: A new mass spectrometric method for peptide sequence analysisBiochemical and Biophysical Research Communications, 1981
- Molecular basis of base substitution hotspots in Escherichia coliNature, 1978